Page last updated: 2024-11-04

sumatriptan and Craniocerebral Trauma

sumatriptan has been researched along with Craniocerebral Trauma in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Craniocerebral Trauma: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, KR1
Kraus, EE1
Zasler, ND1

Reviews

1 review available for sumatriptan and Craniocerebral Trauma

ArticleYear
Medical management of posttraumatic headaches: pharmacological and physical treatment.
    The Journal of head trauma rehabilitation, 1999, Volume: 14, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Craniocerebral Trauma; Ergotamine; Headach

1999